Clinical Trial

hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety and preliminary efficacy of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles hUC-MSC-sEV-001 nasal drops in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple system atrophy, Lewy body dementia, frontotemporal dementia, and amyotrophic lateral sclerosis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-19; most recent amendment 2025-07-01.
Trial Details
NCT Number NCT06607900
Lead Sponsor Xuanwu Hospital, Beijing
Conditions Alzheimer Disease, Parkinson Disease, Lewy Body Dementia, Multiple System Atrophy, Fronto-temporal Dementia, Amyotrophic Lateral Sclerosis
Enrollment 120 participants
Start Date 2025-07-01
Primary Completion 2027-08-31 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-08